Stryker Corp (N:SYK)

Sep 20, 2024 08:00 am ET
Stryker completes acquisition of NICO Corporation, expanding minimally invasive solutions for brain tumor removal and stroke care
PORTAGE, Mich., USA, Sept. 20, 2024 /PRNewswire/ -- Stryker (NYSE: SYK), a global leader in medical technologies, announced today that it has completed the acquisition of NICO Corporation, a privately held company providing a systematic approach to minimally invasive surgery for tumor and intracerebral hemorrhage (ICH) procedures. This acquisition further strengthens Stryker's commitment to neurotechnology through tumor and stroke care.
Sep 17, 2024 11:34 am ET
Stryker completes acquisition of care.ai
Stryker (NYSE: SYK), announced that it has completed the previously announced acquisition of care.ai, a privately held company specializing in delivering AI-assisted virtual care workflows, smart room technology and ambient intelligence solutions....
Sep 12, 2024 10:00 am ET
Eko Health Announces Appointment of Brent Lang, Former CEO of Vocera, to Board of Directors
EMERYVILLE, Calif., Sept. 12, 2024 /PRNewswire/ -- Eko Health, a pioneer in applying artificial intelligence (AI) for early detection of heart and lung diseases, today announced the appointment of Brent D. Lang, former Chairman and CEO of Vocera Communications, to its Board of Directors.
Sep 11, 2024 08:05 am ET
Stryker Expands Foot & Ankle Portfolio With Specialized Offerings Designed to Enhance Surgical Precision and Outcomes
Stryker (NYSE:SYK), a global leader in medical technologies, announced the addition of two new products to its Foot & Ankle portfolio – the Osteotomy Truss System™ (OTS) and Ankle Truss System™ (ATS), recently acquired from 4WEB Medical. The company will feature both the OTS and ATS, the newly acquired Artelon portfolio, and other products at the
Aug 22, 2024 08:00 am ET
Stryker announces definitive agreement to acquire Vertos Medical, Inc., expanding interventional pain management solutions
Stryker (NYSE: SYK), a global leader in medical technologies, announced today a definitive agreement to acquire Vertos Medical Inc., a privately held company providing a minimally invasive solution for treating chronic lower back pain caused by...
Aug 19, 2024 04:00 pm ET
Stryker to participate in the 2024 Wells Fargo Healthcare Conference
Stryker (NYSE:SYK) will participate in the 2024 Wells Fargo Healthcare Conference on Thursday, September 5, at the Encore Boston Harbor. Spencer Stiles, Group President, Orthopaedics and Spine, and Jason Beach, Vice President, Finance and...
Aug 12, 2024 08:00 am ET
Stryker announces definitive agreement to acquire care.ai, a leading virtual care and ambient intelligence solutions platform
Stryker (NYSE: SYK), a global leader in medical technologies, announced today a definitive agreement to acquire care.ai, a privately held company specializing in delivering AI-assisted virtual care workflows, smart room technology and ambient...
Aug 07, 2024 08:00 am ET
Stryker declares an $0.80 per share quarterly dividend
Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.80 per share payable October 31, 2024 to shareholders of record at the close of business on September 30, 2024, representing an increase of 6.7% versus...
Aug 06, 2024 08:05 am ET
Stryker Announces Launch of Pangea Plating System
Stryker (NYSE: SYK), a global leader in medical technologies, announced the launch of its Pangea Plating System, which received FDA clearance in late
Jul 31, 2024 08:45 am ET
Stryker completes acquisition of MOLLI Surgical
SAN JOSE, California, USA, July 31, 2024 /PRNewswire/ -- Stryker (NYSE:SYK), a global leader in medical technologies, announced today that it has completed the acquisition of MOLLI Surgical Inc., a privately held company specializing in the development of wire-free soft tissue localization technology for breast conserving surgery. MOLLI's portfolio further strengthens Stryker's commitment to advancing surgical solutions in breast cancer care.
Jul 31, 2024 08:45 am ET
Stryker completes acquisition of MOLLI Surgical
SAN JOSE, California, USA, July 31, 2024 /CNW/ -- Stryker (NYSE:SYK), a global leader in medical technologies, announced today that it has completed the acquisition of MOLLI Surgical Inc., a privately held company specializing in the development of wire-free soft tissue localization technology for breast conserving surgery. MOLLI's portfolio further strengthens Stryker's commitment to advancing surgical solutions in breast cancer care.
Jul 30, 2024 04:05 pm ET
Stryker reports second quarter 2024 operating results
Stryker (NYSE:SYK) reported operating results for the second quarter of 2024: Second Quarter Results Reported net sales increased 8.5% to $5.4 billionOrganic net sales increased 9.0%Reported operating income margin of...
Jul 30, 2024 08:47 am ET
Stryker's Spine Guidance 5 Software featuring Copilot receives 510(k) clearance from FDA
Q Guidance System with Spine Guidance 5 Software featuring Copilot is a first-to-market technology, pioneering new planning and surgical capabilities
Jul 15, 2024 08:00 am ET
Stryker Completes Acquisition of Artelon, Inc.
Stryker (NYSE: SYK), a global leader in medical technologies, has completed the previously announced acquisition of Artelon, a privately held company specializing in innovative soft tissue fixation products for foot and ankle and sports medicine procedures.
Jul 01, 2024 04:00 pm ET
Stryker to announce financial results for its second quarter of fiscal year 2024
Stryker (NYSE:SYK) announced that it will report financial results for first quarter of fiscal year 2024 on Tuesday, July 30, 2024.  A press release will be issued at approximately 4:05pm ET and available at Stryker - Press Releases that day. The...
Jun 18, 2024 09:07 am ET
Stryker joins Atrium Health affiliate IRCAD North America to advance surgical training and education
PORTAGE, Michigan and CHARLOTTE, North Carolina, USA, June 18, 2024 /PRNewswire/ -- Stryker is bringing its innovative products, platforms and robotic technologies to IRCAD North America (IRCAD NA), a subsidiary of Atrium Health, as part of a multi-year agreement supporting the creation of a cutting-edge experiential education center in Charlotte, North Carolina. IRCAD NA is set to become the cornerstone of the first research building at "The Pearl," a new innovation district currently under construction in the heart of Charlotte. It will attract thousands of medical professionals from aroun
Jun 04, 2024 09:05 am ET
Stryker releases LIFEPAK 35 monitor/defibrillator
LIFEPAK 35, a clinically advanced monitor/defibrillator, reduces caregiver burden and streamlines workflow.1
May 09, 2024 08:00 am ET
Stryker declares a $0.80 per share quarterly dividend
Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.80 per share payable July 31, 2024 to shareholders of record at the close of business on June 28, 2024, representing an increase of 6.7% versus the...
Apr 30, 2024 04:05 pm ET
Stryker reports first quarter 2024 operating results
Stryker (NYSE:SYK) reported operating results for the first quarter of 2024: First Quarter Results Reported net sales increased 9.7% to $5.2 billionOrganic net sales increased 10.0%Reported operating income margin of...
Apr 01, 2024 04:05 pm ET
Stryker to announce financial results for its first quarter of fiscal year 2024
Stryker (NYSE:SYK) announced that it will report financial results for first quarter of fiscal year 2024 on Tuesday, April 30, 2024.  A press release will be issued at approximately 4:05pm ET and available at Stryker - Press Releases that day. The...
Mar 26, 2024 04:05 pm ET
Stryker announces Annual Meeting of Shareholders
Stryker (NYSE:SYK) announced its 2024 Annual Meeting of Shareholders is scheduled as follows: Thursday, May 9, 2024 – 9:30 a.m. Eastern Time The Meeting will be held virtually via the internet. Information about the webcast, which will include...
Mar 26, 2024 03:10 am ET
Stryker launches Gamma4 Hip Fracture Nailing System in Europe
Stryker (NYSE:SYK), a global leader in medical technologies, today announced the release of its Gamma4 Hip Fracture Nailing System in most of the European markets. The newest Gamma system will provide surgeons with the next generation of Stryker’s intramedullary nailing system. The Gamma4 system is designed to treat hip and femur fractures and streamline procedural workflows for surgeons. The system received the CE certification in Europe in September 2023.
Mar 21, 2024 07:15 am ET
Stryker completes acquisition of SERF SAS
MAHWAH, N.J., USA, March 21, 2024 /PRNewswire/ -- Stryker (NYSE: SYK), a leading global medical technology company, announced today that it has completed the previously announced acquisition of SERF SAS, a France-based joint replacement company, from Menix.
Feb 28, 2024 02:10 am ET
First shoulder arthroplasty surgeries using Stryker’s Blueprint® Mixed Reality Guidance System completed in Europe
Stryker (NYSE:SYK), a global leader in medical technologies, today announced that the first shoulder arthroplasty surgeries using Blueprint Mixed Reality (MR) Guidance in Europe have been successfully completed by Professor Julien Berhouet, MD, PhD, CHRU Tours Hospital, France, and Dr. Lionel Neyton, MD, orthopaedic shoulder surgeon at Centre Orthopédique Santy and Hôpital Privé Jean Mermoz in Lyon, France.
Feb 13, 2024 07:00 am ET
Stryker showcases commitment to innovation at AAOS 2024 Annual Meeting
MAHWAH, N.J., Feb. 13, 2024 /PRNewswire/ -- Stryker (NYSE: SYK), a global leader in medical technology, showcases its commitment to innovation and technological advancement in Joint Replacement with the introduction of Triathlon® Hinge as well as the continued evolution of Mako SmartRobotics™ at this year's American Academy of Orthopaedic Surgeons' (AAOS) 2024 Annual Meeting in San Francisco.
Feb 09, 2024 03:15 am ET
CapitalGainsReport Sector Spotlight: Orthobiologics Watchlist (ORHB, ZBH, GMED, SYK)
Orthobiologics represents a dynamic field within healthcare where the body's natural healing mechanisms address osteoarthritis and enhance recovery from tendon and ligament injuries. These therapies signify a significant evolution in medical treatment, offering promising solutions for patients worldwide.
Feb 07, 2024 08:00 am ET
Stryker declares a $0.80 per share quarterly dividend
Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.80 per share payable April 30, 2024 to shareholders of record at the close of business on March 29, 2024, representing an increase of 6.7% versus the...
Feb 05, 2024 08:00 am ET
Stryker to participate in Citi’s 2024 Unplugged Medtech and Life Sciences Access Day
Stryker (NYSE:SYK) will participate in Citi’s 2024 Unplugged Medtech and Life Sciences Access Day on Thursday, February 29, 2024 at Citigroup Headquarters, New York, New York. Glenn Boehnlein, Vice President, Chief Financial Officer and Jason...
Jan 31, 2024 08:31 am ET
Thinking about trading options or stock in Stryker, Meta Platforms, PayPal, Novo Nordisk, or Schlumberger?
NEW YORK, Jan. 31, 2024 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for SYK, META, PYPL, NVO, and SLB.
Jan 31, 2024 08:10 am ET
Stryker Expands Prophecy® Surgical Planning System to Include the New Footprint™, Offering Surgeons a Comprehensive View of the Foot and Ankle
Stryker (NYSE: SYK), a global leader in medical technologies, today announced the launch of Prophecy Footprint, an expansion of the Prophecy Surgical Planning system, offering comprehensive surgical planning across the entire foot. The system will be demonstrated at the
Jan 30, 2024 04:05 pm ET
Stryker reports 2023 operating results and 2024 outlook
Stryker (NYSE:SYK) reported operating results for the fourth quarter and full year of 2023: Fourth Quarter Results Reported net sales increased 11.8% to $5.8 billionOrganic net sales increased 11.4%Reported operating income margin...
Jan 22, 2024 03:00 am ET
Top 4 Spinal Injury Stocks for 2024 (NRX.V, NVRO, SYK, BSX)
Investors eyeing dynamic opportunities in healthcare should take note of the burgeoning growth anticipated in the spinal cord injury market. Projections for robust advancements, driven by enhanced diagnosis and increased global healthcare spending, signal a lucrative trajectory from 2023 to 2032, with a significantly positive CAGR, according to Delveinsights.
Jan 17, 2024 08:00 am ET
New Intermediate Nail and RC Lag Screw Expand Gamma4 Portfolio to Meet the Needs of Surgeons and Their Patients
Stryker (NYSE: SYK), one of the world’s leading medical technologies companies, has expanded its Gamma4 Hip Fracture Nailing System, with the addition of an intermediate nail, the RC Lag Screw, and an anti-rotation clip with sleeve components. Since its launch in August of 2022, the Gamma4 System has been used in over 19,000 cases across more than 850 facilities, solidifying its position as a leading choice in orthopaedic procedures.
Jan 10, 2024 08:35 am ET
First Shoulder Arthroplasty Surgeries Using Stryker’s Blueprint® Mixed Reality Guidance System Completed at Mayo Clinic in Minnesota and at St. Joseph’s Health Care London in Canada
Stryker (NYSE:SYK), one of the world’s leading medical technology companies, today announced that the first shoulder arthroplasty surgeries using Blueprint® Mixed Reality (MR) Guidance have been successfully completed by Dr. Joaquin Sanchez-Sotelo, MD, PhD, Consultant and Professor of Orthopedic Surgery at Mayo Clinic in Rochester, Minn., and Dr. George Athwal at St. Joseph’s Health Care London, Canada.
Jan 08, 2024 08:00 am ET
Stryker announces 2023 sales surpassed $20 billion
Stryker (NYSE:SYK) announced today that it surpassed $20 billion in annual sales for the first time in its history during the month of December, 2023. “We are excited to surpass this major milestone and to share with our employees as we have our...
Jan 05, 2024 08:00 am ET
Stryker to announce financial results for its fourth quarter and full year 2023
Stryker (NYSE:SYK) announced that it will report financial results for fourth quarter and full year 2023 on Tuesday, January 30, 2024.  A press release will be issued at approximately 4:05pm ET and available at Stryker - Press Releases that day....
Dec 19, 2023 03:00 am ET
4 Orthobiologic Stocks Set To Soar In 2024
Welcome to the transformative landscape of orthobiologics, where cutting-edge treatments utilize the body's own cells and healing factors to reverse orthoarthritis effects and expedite recovery from tendon and ligament injuries. These innovations, naturally derived and featuring stem cells, represent a paradigm shift in healthcare.
Dec 18, 2023 08:00 am ET
Stryker announces intent to acquire SERF SAS, enhancing its global joint replacement leadership
MAHWAH, N.J., USA, Dec. 18, 2023 /PRNewswire/ -- Stryker (NYSE: SYK), one of the world's leading medical technology companies, announced today that it has executed a binding offer to Menix to acquire SERF SAS, a France-based joint replacement company.
Dec 07, 2023 08:00 am ET
Stryker announces intention to nominate a new director, Rachel Ruggeri
Stryker (NYSE:SYK) announced today that its Board of Directors intends to nominate Rachel Ruggeri for election to the Company’s Board of Directors at Stryker’s 2024 Annual Meeting of Shareholders, which is expected to be held on May 9, 2024. Ms....
Dec 06, 2023 08:00 am ET
Stryker announces Dr. Srikant Datar will retire from Board of Directors
Stryker (NYSE:SYK) announced today that after 15 years of distinguished service, Dr. Srikant Datar has notified the Company that he will not stand for re-election at Stryker's 2024 Annual Meeting of Shareholders, which is expected to be held on May...
Dec 05, 2023 08:00 am ET
Stryker declares a $0.80 per share quarterly dividend
Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.80 per share payable January 31, 2024 to shareholders of record at the close of business on December 29, 2023, representing an increase of 6.7% versus...
Nov 02, 2023 04:17 pm ET
Stryker reports third quarter 2023 operating results
Stryker (NYSE:SYK) reported operating results for the third quarter of 2023: Third Quarter Results Reported net sales increased 9.6% to $4.9 billionOrganic net sales increased 9.2%Reported operating income margin of 19.0%Adjusted...
Oct 30, 2023 04:05 pm ET
Stryker to participate in the 6th Annual Evercore ISI HealthCONx Conference
Stryker (NYSE:SYK) will participate in the 6th Annual Evercore ISI HealthCONx Conference on Wednesday, November 29, 2023 at the Kimpton EPIC Hotel in Miami, Florida. Glenn Boehnlein, Vice President, Chief Financial Officer and Jason Beach, Vice...
Oct 12, 2023 08:35 am ET
Over 2,400 Surgical Cases Completed Using Stryker’s Q Guidance System with Spine Guidance Software in First Year
Stryker (NYSE:SYK), one of the world’s leading medical technology companies, announced today that its Q Guidance System with Spine Guidance Software has been used to deliver enhanced surgical planning and navigation in over 2,400 spinal cases. The Q Guidance System for both spine and cranial applications will be featured at the Nor
Oct 09, 2023 04:05 pm ET
Stryker to host investor day
Stryker (NYSE:SYK) announced that it will host an Investor Day on Wednesday, November 8, 2023, at 2:30 p.m. Eastern Time, in Mahwah, New Jersey. A simultaneous webcast and replay of the Company's presentation will be available on Stryker's...
Oct 02, 2023 04:05 pm ET
Stryker to announce financial results for its third quarter of fiscal year 2023
Stryker (NYSE:SYK) announced that it will report financial results for third quarter of fiscal year 2023 on Thursday, November 2, 2023.  A press release will be issued at approximately 4:05pm ET and available at Stryker - Press Releases that day....
Sep 21, 2023 02:07 pm ET
Stryker's Triathlon Tritanium Baseplate marks a decade of positive patient impact
Over 1 million Triathlon Cementless Knees implanted globally
Sep 19, 2023 09:20 am ET
Stryker Launches PROstep® MIS Lapidus, a New Minimally Invasive Surgical Option for Treating Patients with Bunions
Stryker (NYSE: SYK), one of the world’s leading medical technology companies, announced the launch of PROstep® MIS Lapidus, a new internal fixation system intended for treating bunions using a minimally invasive surgical reduction of hallux valgus deformity and subsequent fusion of the first metatarsal cuneiform joint. The system will debut at the
Sep 14, 2023 08:03 am ET
A Clearer Vision of Surgery: Stryker Releases its Next-Generation of Advanced Surgical Cameras
Stryker's 1788 camera platform brings enhanced technology to the operating room – including a wider color gamut, more vivid white light and new fluorescence imaging capabilities
Sep 12, 2023 09:20 am ET
Stryker’s Pangea Systems Receive FDA Clearance
Stryker (NYSE: SYK), one of the world’s leading medical technology companies, announced that its Pangea Systems including Femur, Fibula, Tibia, Humerus and Utility have received 510k clearance from the U.S. Food & Drug Administration.
Aug 07, 2023 04:05 pm ET
Stryker to participate in the 2023 Wells Fargo Securities Healthcare Conference
Stryker (NYSE:SYK) will participate in the 2023 Wells Fargo Securities Healthcare Conference on Thursday, September 7, 2023. Glenn Boehnlein, Vice President, Chief Financial Officer and Jason Beach, Vice President, Investor Relations will...
Aug 03, 2023 04:05 pm ET
Stryker reports second quarter 2023 operating results
Stryker (NYSE:SYK) reported operating results for the second quarter of 2023: Second Quarter Results Reported net sales increased 11.2% to $5.0 billionOrganic net sales increased 11.9%Reported operating income margin of 19.3%Adjusted...
Aug 02, 2023 08:00 am ET
Stryker declares a $0.75 per share quarterly dividend
Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.75 per share payable October 31, 2023 to shareholders of record at the close of business on September 29, 2023, representing an increase of 7.9% versus...
Jul 11, 2023 08:30 am ET
Stryker Announces Commercial Launch of Q Guidance System With Cranial Guidance Software
Stryker (NYSE: SYK), one of the world’s leading medical technology companies, has commercially launched its Q Guidance System with Cranial Guidance Software to provide surgeons with an image-based planning and intraoperative guidance system that assists in positioning instruments and identifying patient anatomy during cranial surgery. The software can be used
Jul 06, 2023 08:27 am ET
Stryker launches industry's only fully autonomous guidance system
Ortho Q Guidance system with Ortho Guidance software offers state-of-the-art workflow
Jun 30, 2023 04:05 pm ET
Stryker to announce financial results for its second quarter of fiscal year 2023
Stryker (NYSE:SYK) announced that it will report financial results for second quarter of fiscal year 2023 on Thursday, August 3, 2023.  A press release will be issued at approximately 4:05pm ET and available at Stryker - Press Releases that day....
May 24, 2023 08:30 am ET
Surgeons Successfully Complete First Surgical Cases Using Stryker’s Q Guidance System with Cranial Guidance Software
Stryker (NYSE:SYK), one of the world’s leading medical technology companies, announced that Early Product Surveillance (EPS) cases utilizing its Q Guidance System with Cranial Guidance Software are underway. The technology provides surgeons with image-based planning and an intraoperative guidance system designed to support cranial surgeries.
May 10, 2023 01:01 pm ET
Stryker declares a $0.75 per share quarterly dividend
Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.75 per share payable July 31, 2023 to shareholders of record at the close of business on June 30, 2023, representing an increase of 7.9% versus the...
May 02, 2023 08:00 am ET
Stryker completes acquisition of Cerus Endovascular
KALAMAZOO, Michigan, USA, May 2, 2023 /PRNewswire/ -- Stryker (NYSE:SYK), one of the world's leading medical technology companies, announced today that it has completed the acquisition of Cerus Endovascular Ltd., a privately held, commercial-stage, medical device company engaged in the design and development of neurointerventional devices for the treatment of intracranial aneurysms. Cerus Endovascular's CE Marked products, the Contour Neurovascular System and the Neqstent Coil Assisted Flow Diverter, will expand Stryker's current portfolio of aneurysm treatment solutions.
May 01, 2023 04:05 pm ET
Stryker reports first quarter 2023 operating results
Stryker (NYSE:SYK) reported operating results for the first quarter of 2023: First Quarter Results Reported net sales increased 11.8% to $4.8 billionOrganic net sales increased 13.6%Reported operating income margin of 15.4%Adjusted operating...
Mar 30, 2023 04:05 pm ET
Stryker to announce financial results for its first quarter of fiscal year 2023
Stryker (NYSE:SYK) announced that it will report financial results for first quarter of fiscal year 2023 on Monday, May 1, 2023.  A press release will be issued at approximately 4:05pm ET and available at Stryker - Press Releases that day. The...
Mar 30, 2023 08:27 am ET
Stryker Now Offers the Only FDA-Cleared Pyrocarbon Bearing Material Option for Shoulder Hemiarthroplasty
Stryker (NYSE:SYK), one of the world’s leading medical technology companies, today announced that Armodios M. Hatzidakis, MD, FAAOS, Western Orthopaedics, PC, Denver Surgery Center and Rose Medical Center, has successfully completed the first case in the United States, since the De Novo clearance, using the Tornier Pyrocarbon Humeral Head. Stryker’s De Novo request was granted in late 2022 after completing an Investigational Device Exemption (IDE) study with the FDA.
Mar 28, 2023 01:12 pm ET
Stryker announces Annual Meeting of Shareholders
Stryker (NYSE:SYK) announced its 2023 Annual Meeting of Shareholders is scheduled as follows: Wednesday, May 10, 2023 – 9:00 a.m. Eastern Time The Meeting will be held virtually via the internet. Information about the webcast, which will...
Feb 17, 2023 09:30 am ET
Stryker’s Q Guidance System for cranial applications receives FDA clearance
Stryker (NYSE:SYK), one of the world’s leading medical technology companies, today announced that its Q Guidance System with Cranial Guidance Software received 510(k) clearance from the U.S. Food and Drug Administration. The Q Guidance System is an image-based planning and intraoperative guidance system designed to support cranial surgeries. Recently
Feb 09, 2023 08:00 am ET
Stryker declares a $0.75 per share quarterly dividend
Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.75 per share payable April 28, 2023 to shareholders of record at the close of business on March 31, 2023, representing an increase of 7.9% versus the...
Feb 01, 2023 08:34 am ET
Thinking about trading options or stock in Meta, Baidu, Apple, Stryker, or NVIDIA?
NEW YORK, Feb. 1, 2023 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for META, BIDU, AAPL, SYK, and NVDA.
Jan 31, 2023 04:05 pm ET
Stryker reports 2022 operating results and 2023 outlook
Stryker (NYSE:SYK) reported operating results for the fourth quarter and full year of 2022: Fourth Quarter Results Reported net sales increased 10.7% to $5.2 billionOrganic net sales increased 13.2%Reported operating income margin of...
Dec 28, 2022 04:05 pm ET
Stryker to host conference call on January 31, 2023
Stryker (NYSE:SYK) announced that it will host a conference call on Tuesday, January 31, 2023 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ending December 31, 2022 and provide an operational update. Final...
Dec 13, 2022 10:27 am ET
Stryker launches Citrefix™ Suture Anchor System, featuring award-winning Citregen biomaterial designed to support bone regeneration and the natural healing process
Stryker (NYSE:SYK) today announced the launch of Citrefix™, a suture anchor system for foot and ankle surgical procedures. The new system uses Citregen™, an award-winning bioresorbable material designed to mimic the chemistry and structure of native bone.1
Dec 07, 2022 08:00 am ET
Stryker declares a $0.75 per share quarterly dividend
Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.75 per share payable January 31, 2023 to shareholders of record at the close of business on December 30, 2022, representing an increase of  7.9% versus...
Nov 14, 2022 06:00 am ET
Stryker opens the OR of the Future for customers to experience tomorrow's OR today
This operating room model puts increased focus on design for patient and staff safety, productivity and operational efficiency—further enabling improvements in quality of care
Nov 03, 2022 04:05 pm ET
Stryker to participate in the 5th Annual Evercore ISI HealthCONx Conference
Stryker (NYSE:SYK) will participate in the 5th Annual Evercore ISI HealthCONx Conference on Thursday, December 1, 2022. Kevin Lobo, Chair and Chief Executive Officer and Jason Beach, Vice President, Investor Relations will represent the Company...
Oct 31, 2022 04:05 pm ET
Stryker reports third quarter 2022 operating results
Stryker (NYSE:SYK) reported operating results for the third quarter of 2022: Third Quarter Results Reported net sales increased 7.7% to $4.5 billionOrganic net sales increased 9.9%Reported operating income...
Oct 12, 2022 08:45 am ET
Stryker to Showcase Innovative Portfolio of Spine Solutions at the North American Spine Society Meeting
Stryker (NYSE:SYK), one of the world’s leading medical technology companies, will feature its suite of procedural solutions for spinal surgery, including its award-winning Q Guidance System with Spine Guidance Software, during the North American Spine Society (NASS) annual meeting in Chicago, Oct. 12–15 (booth #4211).
Oct 04, 2022 08:45 am ET
Stryker Launches Monterey AL Interbody System with New Pre-clinical Data
Stryker (NYSE:SYK), one of the world’s leading medical technology companies, announced today the launch of the Monterey AL Interbody System, a stand-alone interbody fusion device designed for anterior lumbar interbody fusion (ALIF). Monterey AL is made up of both solid and porous structures within a single implant, leveraging Stryker’s proprietary Tritanium In-Growth Technology, a material designed to mimic cancellous bone and provide an environment favorable to bone regeneration and fusion.1-4 New data demonstrates that undifferentiated stem cells grown on Tritanium exhibited osteo

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.